Stallergenes Greer, a biopharmaceutical company specialising in allergen immunotherapy (AIT), announces that the European Commission (EC) has approved the extension of indication of Palforzia® ...
DBV Technologies Announces Positive 3-Year Results from EPITOPE Phase 3 Open-Label Extension Study EPITOPE OLE data demonstrates continued improvement in treatment ...
In some cases, it can also ease allergies symptoms and respiratory conditions, according to the American Academy of Allergy, Asthma & Immunology. We have meticulously tried and tested some of the ...